3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
18
Phase 1
6
Phase 3
3
Phase 4
2
Phase 2/3
2
Phase 1/2
2
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
100
Leukemia, Myeloid, Acute
93
Precursor Cell Lymphoblastic Leukemia-Lymphoma
74
Myeloproliferative Disorders
71
Multiple Myeloma
65
Lymphoma, Non-Hodgkin
62
Leukemia
62
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Leukemia, Lymphocytic, Chronic, B-Cell
58
Hodgkin Disease
58
Primary Myelofibrosis
52
Lymphoma, Mantle-Cell
45
Lymphoma, Large B-Cell, Diffuse
42
Burkitt Lymphoma
42
Lymphoma, Follicular
41
Leukemia, Myeloid, Chronic-Phase
40
Lymphoma, B-Cell, Marginal Zone
39
Lymphoma
39
Lymphoma, Large-Cell, Immunoblastic
38
Congenital Abnormalities
37
Lymphoma, T-Cell, Cutaneous
35
Leukemia, Myeloid, Accelerated Phase
35
Sezary Syndrome
32
Mycosis Fungoides
32
Leukemia, Myelomonocytic, Chronic
32
Blast Crisis
32
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
28
Pdgfra-Associated Chronic Eosinophilic Leukemia
27
Leukemia, Neutrophilic, Chronic
27
Neoplasms, Plasma Cell
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Mastocytosis, Systemic
×
Myeloid
×
Clear all
NCT02441166
2019-07-15
EvaTryMS
University Hospital, Toulouse
Phase NA
Completed
250 enrolled